Oktreotid Teva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Oktreotid Teva, is a somatostatin analog presented as a unknown/unknown for injection use. It treats hormone‑secreting tumors and related endocrine disorders in adults.

GNH USA supplies Oktreotid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Oktreotid Teva is a somatostatin analog that modulates hormone secretion in several endocrine‑related conditions. - Acromegaly: reduces excessive growth hormone production and helps control disease activity. - Neuroendocrine tumors: controls the release of hormones and alleviates symptoms such as flushing and diarrho­ di­ t . - Carcinoid syndrome: the d  ​      """"  "  "" " " " "" " " " "" " " " " " " " " " " " " " " " " " " """ 

Common  

}]